These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26809289)

  • 1. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
    Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
    Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation.
    Askren MK; Jung M; Berman MG; Zhang M; Therrien B; Peltier S; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
    Breast Cancer Res Treat; 2014 Sep; 147(2):445-55. PubMed ID: 25138546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment worry and neurocognitive responses in women with breast cancer.
    Berman MG; Askren MK; Jung M; Therrien B; Peltier S; Noll DC; Zhang M; Ossher L; Hayes DF; Reuter-Lorenz PA; Cimprich B
    Health Psychol; 2014 Mar; 33(3):222-31. PubMed ID: 23914817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive Patients.
    Kozora E; Uluğ AM; Erkan D; Vo A; Filley CM; Ramon G; Burleson A; Zimmerman R; Lockshin MD
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1655-1663. PubMed ID: 26946337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered neural activation during prepotent response inhibition in breast cancer survivors treated with chemotherapy: an fMRI study.
    Kam JW; Boyd LA; Hsu CL; Liu-Ambrose T; Handy TC; Lim HJ; Hayden S; Campbell KL
    Brain Imaging Behav; 2016 Sep; 10(3):840-8. PubMed ID: 26489975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain connectivity tracks effects of chemotherapy separately from behavioral measures.
    Kardan O; Reuter-Lorenz PA; Peltier S; Churchill NW; Misic B; Askren MK; Jung MS; Cimprich B; Berman MG
    Neuroimage Clin; 2019; 21():101654. PubMed ID: 30642760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.
    Menning S; de Ruiter MB; Veltman DJ; Boogerd W; Oldenburg HS; Reneman L; Schagen SB
    PLoS One; 2017; 12(3):e0171724. PubMed ID: 28267750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prechemotherapy alterations in brain function in women with breast cancer.
    Cimprich B; Reuter-Lorenz P; Nelson J; Clark PM; Therrien B; Normolle D; Berman MG; Hayes DF; Noll DC; Peltier S; Welsh RC
    J Clin Exp Neuropsychol; 2010 Mar; 32(3):324-31. PubMed ID: 19642048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
    Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
    Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.
    Deprez S; Vandenbulcke M; Peeters R; Emsell L; Smeets A; Christiaens MR; Amant F; Sunaert S
    J Clin Oncol; 2014 Jul; 32(19):2031-8. PubMed ID: 24868029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural response to working memory demand predicts neurocognitive deficits in HIV.
    Cohen RA; Siegel S; Gullett JM; Porges E; Woods AJ; Huang H; Zhu Y; Tashima K; Ding MZ
    J Neurovirol; 2018 Jun; 24(3):291-304. PubMed ID: 29280107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.
    Apple AC; Ryals AJ; Alpert KI; Wagner LI; Shih PA; Dokucu M; Cella D; Penedo FJ; Voss JL; Wang L
    Neuroimage Clin; 2017; 14():685-691. PubMed ID: 28377882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased resting-state cerebellar-cortical connectivity in breast cancer survivors with cognitive complaints after chemotherapy.
    Park HY; Lee H; Sohn J; An SK; Namkoong K; Lee E
    Sci Rep; 2021 Jun; 11(1):12105. PubMed ID: 34103606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study.
    López Zunini RA; Scherling C; Wallis N; Collins B; MacKenzie J; Bielajew C; Smith AM
    Brain Imaging Behav; 2013 Dec; 7(4):460-77. PubMed ID: 23242968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.